Humans have shared anecdotal reports about how taking GLP-1RAs for other indications helped them reduce their alcohol consumption as well
These practices may be due to medical providers having biases about which patients will be able to afford certain medications, or about the effectiveness of medications in different patient groups. And again, not all insurance companies will cover them, and even if they do, co-pays and out-of-pocket costs can be prohibitive
I could still enjoy dinner, and then move on the next day, Stanford says
In this systematic review, the authors conducted a comprehensive analysis of clinical trials to determine the impact of GLP-1 receptor agonists in reducing substance use disorder in patients
Until a couple months ago, these medications were only available as injectables, which discouraged some patients
The study also revealed a potential knowledge gap, as participants often overestimated their fruit and vegetable intake in self-reports compared to their detailed food records, suggesting a need for better dietary education on portion sizes
